Takeda Pharmaceutical Company Limited v. Norwich Pharmaceuticals Inc.
Takeda Pharmaceutical Company Limited v. Norwich Pharmaceuticals Inc.
Opinion
Case: 23-1374 Document: 37 Page: 1 Filed: 05/04/2023
NOTE: This disposition is nonprecedential.
United States Court of Appeals for the Federal Circuit ______________________ TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA PHARMACEUTICALS U.S.A., INC., Plaintiffs-Appellees v. NORWICH PHARMACEUTICALS INC., Defendant-Appellant ______________________ 2023-1374 ______________________ Appeal from the United States District Court for the District of New Jersey in No. 2:20-cv-08966-SRC-CLW, Judge Stanley R. Chesler. ______________________ JUDGMENT ______________________ EDGAR HAUG, Haug Partners LLP, New York, NY, ar- gued for plaintiffs-appellees. Also represented by KAITLIN FARRELL, PORTER F. FLEMING, SHEILA MORTAZAVI, ANDREW SCOTT ROPER.
CHAD A. LANDMON, Axinn, Veltrop & Harkrider LLP, Hartford, CT, argued for defendant-appellant. Also repre- sented by THOMAS K. HEDEMANN, EDWARD M. MATHIAS, Case: 23-1374 Document: 37 Page: 2 Filed: 05/04/2023
FRANCIS H. MORRISON, III; JASON MURATA, San Francisco, CA. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (MOORE, Chief Judge, MAYER and HUGHES, Circuit Judges).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT
May 4, 2023 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court
Case-law data current through December 31, 2025. Source: CourtListener bulk data.